METTL3 and head and neck squamous cell carcinoma: Likewise, METTL3- and METTL14-mediated m6A modification of LncAROD enhanced its stability and promoted ternary complex formation with HSPA1A and YBX1, driving progression in head and neck squamous cell carcinoma (35).